The potential impact of new generation molecular point-of-care tests on gonorrhoea and chlamydia in a setting of high endemic prevalence

Sexual Health

Volumn 10, Issue 4, 2013, Pages 348-356

  Hui, Ben B ^a   Wilson, David P ^a   Ward, James S ^b   Guy, Rebecca J ^a   Kaldor, John M ^a   Law, Matthew G ^a   Hocking, Jane S ^c   Regan, David G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Australia; Indigenous; mathematical model; rapid tests; STIs; vulnerable populations.

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; GONORRHEA; HUMAN; MALE; NEISSERIA GONORRHOEAE; POINT OF CARE TESTING; THERAPY DELAY; TIME TO TREATMENT; CHLAMYDIA INFECTIONS; POINT OF CARE SYSTEM; PREVALENCE;

CHLAMYDIA INFECTIONS; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; POINT-OF-CARE SYSTEMS; PREVALENCE;

EID: 84881133102     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH13026     Document Type: Article

References (53)

1. Gerbase A, Stein C, Levinson J, Htun Y. Global burden of sexually transmitted diseases (excluding HIV) in the year 2000: Global burden of disease 2000. Geneva: WHO; 2000
2. Wasik M, Djuric Kachli M. A review of common sexually transmitted diseases. Formulary 2009; 44(3): 78-86
3. Australian Government Department of Health and Ageing (DoHA). Third national Aboriginal and Torres Strait Islander blood borne viruses and sexually transmissible infections strategy 2010-2013. Canberra: DoHA; 2010
4. Guy R, Garton L, Taylor-Thompson D, Silver B, Hengel B, Knox J, et al. The 2010 baseline prevalence study conducted by the STRIVE trial. Australasian Sexual Health Conference, 26-28 September 2011; 2011; National Convention Centre, Canberra, ACT, Australia
5. Bowden FJ, Fethers K. "Let's not talk about sex": Reconsidering the public health approach to sexually transmissible infections in remote Indigenous populations in Australia. Med J Aust 2008; 188 (3): 182-4
6. Guy R, Ward J, Smith K, Su J-Y, Huang R-L, Tangey A, et al. The impact of sexually transmissible infection programs in remote Aboriginal communities in Australia: A systematic review. Sex Health 2012; 9(3): 205-12
7. van Dommelen L, van Tiel FH, Ouburg S, Brouwers EEHG, Terporten PHW, Savelkoul PHM, et al. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect 2010; 86(5): 355-9. doi:10.1136/sti.2010.042598
8. Mahilum-Tapay L, Laitila V, Wawrzyniak JJ, Lee HH, Alexander S, Ison C, et al. New point of care chlamydia rapid test - bridging the gap between diagnosis and treatment: Performance evaluation study. BMJ 2007; 335(7631): 1190-4. doi:10.1136/bmj.39402.463 854.AE
9. Watchirs Smith LA, Hillman R, Ward J, Whiley DM, Causer L, Skov S, et al. Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: A systematic review of operational and performance characteristics. Sex Transm Infect 2012; 89: 320-326. doi:10.1136/ sextrans-2012-050656
10. Gift TL. Nucleic acid amplification tests are more accurate and costeffective than the chlamydia rapid test for diagnosing genital chlamydia. Evid Based Nurs 2010; 14(2): 45-6
11. Gift TL, Pate M, Hook EW, Kassler WJ. The rapid test paradox: When fewer cases detected lead to more cases treated: A decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 1999; 26(4): 232-40. doi:10.1097/00007435- 199904000-00010
12. Loubiere S, Moatti JP. Economic evaluation of point-of-care diagnostic technologies for infectious diseases. Clin Microbiol Infect 2010; 16(8): 1070-6. doi:10.1111/j.1469-0691.2010.03280.x
13. Watchirs Smith L, Hillman R, Ward J, Whiley DM, Causer L, Skov S, et al. Point-of-care tests for the detection of N. gonorrhoeae; a systematic review of operational characteristics and performance. Australasian Sexual Health Conference, 26-28 Sept 2011; 2011; National Convention Centre, Canberra, ACT, Australia
14. Cheng H, Macaluso M, Vermund SH, Hook EW. Relative accuracy of nucleic acid amplification tests and culture in detecting chlamydia in asymptomatic men. J Clin Microbiol 2001; 39(11): 3927-37. doi:10.1128/JCM.39.11.3927-3937.2001
15. Nadala E-C, Goh BT, Magbanua J-P, Barber P, Swain A, Alexander S, et al. Performance evaluation of a new rapid urine test for chlamydia in men: Prospective cohort study BMJ 2009; 339(7717): 389-96
16. Huang W, Gaydos CA, Barnes MR, Jett-Goheen M, Blake DR. Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting. Sex Transm Infect 2013; 89(2): 108-14
17. Tabrizi S, Twin J, Unemo M, Limnios EA, Guy R. Analytical performance of GeneXpert® CT/NG, the first real-time PCR pointof- care assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. 13th IUSTI World Congress, 15-17 Oct 2012; Melbourne Convention and Exhibition Centre, Melbourne, Victoria, Australia. 2012;
18. Anderson RM, May RM. Infectious diseases of humans: Dynamics and control. New York: Oxford University Press; 1991
19. Keeling MJ, Rohani P. Modeling infectious diseases in human and animals. Princeton: Princeton University Press; 2008
20. Smith K, Watson C, Senior K, Latif A. Central Australian STI risk factor study. Alice Springs: Sexual Health and BBV Unit, Centre for Disease Control, Department of Health and Families, Northern Territory Government; 2008
21. Garnett GP, Mertz KJ, Finelli L, Levine WC, St Louis ME. The transmission dynamics of gonorrhoea: Modelling the reported behaviour of infected patients from Newark, New Jersey. Philos Trans R Soc Lond B Biol Sci 1999; 354(1384): 787-97. doi:10.1098/ rstb.1999.0431
22. De Visser RO, Smith AMA, Rissel CE, Richters J, Grulich AE. Sex in Australia: Heterosexual experience and recent heterosexual encounters among a representative sample of adults. Aust N Z J Public Health 2003; 27(2): 146-54
23. Johnson LF, Alkema L, Dorrington RE. A Bayesian approach to uncertainty analysis of sexually transmitted infection models Sex Transm Infect 2010; 86: 169-74. doi:10.1136/sti.2009.037341
24. Nganampa Health Council. Nganampa Health Council 2011 annual report. Alice Spring: Nganampa Health Council; 2012. Available at www.nganampahealth. com.au/download-reports-a-documents/doc- download/181-nganampa-health-council- 2011-annual-report.html [verified 2012 April 5].
25. Latif A, Smith K. STI screening conducted in NT Department of Health and Community Services and Community Controlled Health Services in Central Australia in 2004. The Northern Territory Disease Control Bulletin 2004; 11(4): 18-20
26. Huang R-L, Torzillo PJ, Hammond VA, Coulter ST, Kirby AC. Epidemiology of sexually transmitted infections on the Anangu Pitjantjatjara Yankunytjatjara Lands: Results of a comprehensive control program. Med J Aust 2008; 189(8): 442-5
27. Schwebke JR, Sadler R, Sutton JM, Hook EW. Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic. Sex Transm Dis 1997; 24(4): 181-4. doi:10.1097/00007435-1997040 00-00001
28. Hook EW, Spitters C, Reichart CA, Neumann TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272(11): 867-70. doi:10.1001/jama.1994. 03520110047027
29. Garton L, Guy R, Silver B, Taylor-Thompson D, Hengel B, Knox J, et al. Australia's largest clustered randomised trial in Aboriginal sexual health: Progress toward a goal. Australasian Sexual Health Conference, 26-28 Sept 2011; 2011; National Convention Centre, Canberra, ACT, Australia
30. Vickerman P, Watts C, Peeling RW, Mabey D, Alary M. Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers. Sex Transm Infect 2006; 82: 403-12. doi:10.1136/sti.20 06.020107
31. Northern Territory Government. Medicines, Poisons and Therapeutic Goods Act (No 13 of 2012, section 89) Darwin: Northern Territory Government; 2012. Available at http://www. austlii.edu.au/au/legis/nt/num-act/ mpatga201213o2012425/s89.html [verified May 2013].
32. Vickerman P. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect 2003; 79(5): 363-7. doi:10.1136/sti.79.5.363
33. Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess 2010; 14(29): 1-97
34. Katz AR, Effler PV, Ohye RG, Brouillet B, Veneranda M, Lee C, et al. False positive gonorrhea test results with a nucleic acid amplification test: The impact of low prevalence on positive predictive value. Clin Infect Dis 2004; 38(6): 814-9. doi:10.1086/381895
35. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002; 359(9309): 881-4. doi:10.1016/S0140-6736(02)07948-5
36. The Kirby Institute. Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and evaluation Report 2011. Sydney: The Kirby Institute, the University of New South Wales; 2011
37. Dietz K, Hadeler KP. Epidemiological models for sexually transmitted diseases. J Math Biol 1988; 26(1): 1-25. doi:10.1007/BF00280169
38. Ong JB, Fu X, Lee GKK, Chen MI. Comparability of results from pair and classical model formulations for different sexually transmitted infections. PLoS ONE 2012. 7(6): Doi:10.1371/journal. pone.0039575
39. Rissel CE, Richters J, Grulich AE, de Visser RO, Smith AMA. Sex in Australia: Selected characteristics of regular sexual relationships. Aust N Z J Public Health 2003; 27(2): 124-30. doi:10.1111/j.1467-842X. 2003.tb00799.x
40. De Visser RO, Smith AMA, Rissel CE, Richters J, Grulich AE. Sex in Australia: Safer sex and condom use among a representative sample of adults. Aust N Z J Public Health 2003; 27(2): 223-9. doi:10.1111/ j.1467-842X.2003. tb00812.x
41. Hooper RR, Reynolds GH, Jones OG, Zaidi A, Wiesner PJ, Latimer K, et al. Cohort study of venereal disease. 1: The risk of gonorrhoea transmission from infected women to men. Am J Epidemiol 1978; 108 (2): 136-44
42. Regan D, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008; 198(3): 349-58. doi:10.1086/589883
43. McCutchan JA. Epidemiology of veneral urethritis: Comparison of gonorrhea and nongonococcal urethritis. Rev Infect Dis 1984; 6(5): 669-88. doi:10.1093/clinids/6.5.669
44. Harrison WO, Hooper RR, Wiesner PJ, Campbell AF, Karney WW, Reynolds GH, et al. A trial of minocycline given after exposure to prevent gonorrhea. N Engl J Med 1979; 300(19): 1074-8. doi:10.10 56/NEJM197905103001903
45. Brunham RC, Garnett GP, Swinton J, Anderson RM. Gonococcal infection and human fertility in sub-Saharan Africa Proc R Soc Lond B Biol Sci 1991; 246(1316): 173-7. doi:10.1098/rspb.1991.0141
46. Althaus CL, Heijne JCM, Roellin A, Low N. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics. 2010; 2: 123-31. doi:10.1016/j.epidem.2010.04.002
47. Parks KS, Dixon PB, Richey CM, Hook EW. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24(4): 229-35. doi:10.1097/00007435-199704000-00008
48. Morré SA, Sillekens PT, Jacobs MV, de Blok S, Ossewaarde JM, van Aarle P, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Pathol 1998; 51(3): 149-54. doi:10.1136/ mp.51.3.149
49. Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted disease: The case for screening. Prev Med 2003; 36(4): 502-9. doi:10.1016/S0091-7435(02) 00058-0
50. Korenromp EL, Sudaryo MK, De Vlas SJ, Gray RH, Sewankambo NK, Serwadda D, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002; 13(2): 91-101. doi:10.1258/0956462021924712
51. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: Noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142(11): 914-25. doi:10.7326/0003-4819-142-11- 200506070-00010
52. Rockett R, Goire N, Limnios A, Turra M, Higgens G, Lambert SB, et al. Evaluation of the Cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Infect 2010; 86: 470-3. doi:10.1136/sti.2010. 042812
53. Spigarelli MG. Urine gonococcal/chlamydia testing in adolescents. Curr Opin Obstet Gynecol 2006; 18(5): 498-502. doi:10.1097/01. gco.0000242951.87125. b2